These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 7910061

  • 1. Lymphocyte proliferation in uremic patients: correlation with zinc status.
    Shu KH, Lu YS, Chen CH, Chen DC, Lee SH, Lian JD.
    J Formos Med Assoc; 1993 Nov; 92(11):1017-20. PubMed ID: 7910061
    [Abstract] [Full Text] [Related]

  • 2. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
    Langhoff E, Ladefoged J, Odum N.
    Int Arch Allergy Appl Immunol; 1986 Nov; 81(1):5-11. PubMed ID: 3488966
    [Abstract] [Full Text] [Related]

  • 3. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
    Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H.
    Clin Nephrol; 1992 Nov; 38(5):271-6. PubMed ID: 1451340
    [Abstract] [Full Text] [Related]

  • 4. The immune status of the uremic patient: hemodialysis vs CAPD.
    Schollmeyer P, Bozkurt F.
    Clin Nephrol; 1988 Nov; 30 Suppl 1():S37-40. PubMed ID: 3052959
    [Abstract] [Full Text] [Related]

  • 5. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
    Langhoff E, Ladefoged J.
    Proc Eur Dial Transplant Assoc; 1983 Nov; 20():230-5. PubMed ID: 6657659
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
    Griveas I, Visvardis G, Fleva A, Papadopoulou D, Mitsopoulos E, Kyriklidou P, Manou E, Ginikopoulou E, Meimaridou D, Paulitou A, Sakellariou G.
    Ren Fail; 2005 Nov; 27(3):279-82. PubMed ID: 15957543
    [Abstract] [Full Text] [Related]

  • 8. Serial cell-mediated immunological changes in terminal uremic patients on continuous ambulatory peritoneal dialysis therapy.
    Lin CY, Huang TP.
    Am J Nephrol; 1988 Nov; 8(5):355-62. PubMed ID: 2977061
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells.
    Mettang T, Fritz P, Weber J, Machleidt C, Hübel E, Kuhlmann U.
    Clin Nephrol; 1990 Sep; 34(3):136-41. PubMed ID: 1699691
    [Abstract] [Full Text] [Related]

  • 11. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epidermal Langerhans cells in uremic patients on hemodialysis or continuous ambulatory peritoneal dialysis.
    Mettang T, Fritz P, Weber J, Machleidt C, Hübel E, Kiefer T, Kuhlmann U.
    Nephron; 1993 May; 65(2):278-83. PubMed ID: 8247193
    [Abstract] [Full Text] [Related]

  • 15. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis.
    Pastor MC, Sierra C, Bonal J, Teixidó J.
    Am J Nephrol; 1993 May; 13(4):238-43. PubMed ID: 8267019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uremia as a state of immune deficiency.
    Birkeland SA.
    Scand J Immunol; 1976 May; 5(1-2):107-15. PubMed ID: 131369
    [Abstract] [Full Text] [Related]

  • 18. [Abnormalities of cellular immunity in uremic patients].
    Matsumoto Y.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):733-42. PubMed ID: 8377286
    [Abstract] [Full Text] [Related]

  • 19. [Study on the assay of uremic protein-binding inhibitors: furan compound and hippuric acid].
    Tanaka Y.
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):643-51. PubMed ID: 1749115
    [Abstract] [Full Text] [Related]

  • 20. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O, Boner G, Rosenfeld JB.
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.